These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 8031169)

  • 1. [Four cases of recurrent breast cancer effectively treated by the new antitumor agent, CPT-11 (irinotecan)].
    Doihara H; Takashima S; Yokoyama N
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1263-6. PubMed ID: 8031169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A late phase II study of CPT-11 (irinotecan) in advanced breast cancer. CPT-11 Study Group on Breast Cancer].
    Taguchi T; Tominaga T; Ogawa M; Ishida T; Morimoto K; Ogawa N
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1017-24. PubMed ID: 8210251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer].
    Taguchi T; Yoshida Y; Izuo M; Ishida T; Ogawa M; Nakao I; Tominaga T; Ohkawa T; Oguro M; Yoshida M
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):83-90. PubMed ID: 8291919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer].
    Nishimura G; Satou T; Yoshimitsu Y; Kurosaka Y; Fujimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):93-7. PubMed ID: 7826085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A pilot study of irinotecan hydrochloride for metastatic breast cancer--efficacy as a salvage therapy].
    Ikeda H; Koshiba R
    Gan To Kagaku Ryoho; 2000 May; 27(5):723-7. PubMed ID: 10832441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].
    Futatsuki K; Wakui A; Nakao I; Sakata Y; Kambe M; Shimada Y; Yoshino M; Taguchi T; Ogawa N
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1033-8. PubMed ID: 8210254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer].
    Sakata Y; Shimada Y; Yoshino M; Kambe M; Futatsuki K; Nakao I; Ogawa N; Wakui A; Taguchi T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1039-46. PubMed ID: 8210255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A late phase II study of CPT-11 on uterine cervical cancer and ovarian cancer. Research Groups of CPT-11 in Gynecologic Cancers].
    Takeuchi S; Dobashi K; Fujimoto S; Tanaka K; Suzuki M; Terashima Y; Hasumi K; Akiya K; Negishi Y; Tamaya T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1681-9. PubMed ID: 1872624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Late phase II clinical study of irinotecan hydrochloride (CPT-11) in the treatment of malignant lymphoma and acute leukemia. The CPT-11 Research Group for Hematological Malignancies].
    Ota K; Ohno R; Shirakawa S; Masaoka T; Okada K; Ohashi Y; Taguchi T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1047-55. PubMed ID: 8210256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of postoperative local skin recurrence of breast cancer successfully treated with chemotherapy of irinotecan hydrochloride (CPT-11)].
    Enomoto K; Amano S; Sakurai K; Negishi N
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1782-5. PubMed ID: 16315940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An early phase II study of CPT-11 in gynecologic cancers. Research Group of CPT-11 in Gynecologic Cancers].
    Takeuchi S; Takamizawa H; Takeda Y; Ohkawa T; Tamaya T; Noda K; Sugawa T; Sekiba K; Yakushiji M; Taguchi T
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):579-84. PubMed ID: 2012400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of CI-973 [SP-4-3(R)]-1,1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N') platinum in patients with refractory advanced breast cancer.
    Theriault RL; Walters RS; Holmes FA; Esparza-Guerra L; Kowal C; Hortobagyi GN
    Cancer Chemother Pharmacol; 1996; 38(3):289-91. PubMed ID: 8646805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of recurrent breast cancer with bone metastasis causing pancytopenia--efficacy of low-dose CPT-11+ MPA].
    Inoue M; Kimura M; Horino K; Nishimura T; Kuhara H; Nakano M; Kaneda H; Kume S; Arima T; Uemura K
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):543-5. PubMed ID: 15853225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Weekly paclitaxel therapy for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group].
    Negoro S; Fukuoka M; Niitani H; Suzuki A; Nakabayashi T; Kimura M; Motomiya M; Kurita Y; Hasegawa K; Kuriyama T
    Gan To Kagaku Ryoho; 1991 May; 18(6):1013-9. PubMed ID: 1851408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
    Toi M; Taniguchi T; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1995 May; 22(6):799-804. PubMed ID: 7755388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancer.
    Nicholson BP; Paul DM; Hande KR; Shyr Y; Meshad M; Cohen A; Johnson DH
    Clin Breast Cancer; 2000 Jul; 1(2):136-43; discussion 144. PubMed ID: 11899652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A phase I study of weekly administration of CPT-11 in lung cancer].
    Fukuoka M; Negoro S; Niitani H; Furue H; Hasegawa K; Hara Y; Hara N; Taguchi T
    Gan To Kagaku Ryoho; 1990 May; 17(5):993-7. PubMed ID: 2159268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.
    Rowinsky EK; Grochow LB; Ettinger DS; Sartorius SE; Lubejko BG; Chen TL; Rock MK; Donehower RC
    Cancer Res; 1994 Jan; 54(2):427-36. PubMed ID: 8275479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase I clinical study of CPT-11. Research group of CPT-11].
    Taguchi T; Wakui A; Hasegawa K; Niitani H; Furue H; Ohta K; Hattori T
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):115-20. PubMed ID: 2404454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.